Patients with diet protein lose more fat and less lean mass, than patients with hypocaloric diet

-Preliminary results of the ProKal study were presented at the 2nd Latin American Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy).

-during 4 days was discussed on the epidemiology, genetics and diagnosis of diabetes type 2 (DM2), obesity and hypertension in Latin American countries.

Barcelona, March 2012.- From 22 to 25 March was held in Rio de Janeiro the 2nd Latin American Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy), a biannual International Congress which in its previous edition gathered around 2,000 doctors from 52 different countries. PronoKal ® Group, international company present in 11 countries and specialized in addressing overweight and obesity through weight loss methods based on diet protein is this year one of the main collaborators of the meeting.

This second edition of the Congress presented new perspectives for tackling diabetes type 2 (DM2), obesity and hypertension from an essentially regional approach, analyzing and discussing the epidemiology, genetics and Diagnostics present in Latin American countries. Between conferences and symposia, this edition welcomed more than 25 discussion sessions, among which highlighted the Symposium clinical evidence of dietary protein as a medical tool for weight loss ”, given by Dr. Felipe Casanueva (Spain) and DRA. Isabella Bussade (Brazil).

Success of dietary protein in obese patients

Dr. Felipe Casanueva, Chairman of the International Society of Endocrinology (ISE) and Chief of the service of Endocrinology and nutrition of the Clinical Hospital of Santiago de Compostela, along with the DRA. Isabella Bussade, researcher in the Group of obesity and food in Brazil disorders, through its symposium presented the results of the ProKal study, a clinical trial that evaluated the effectiveness of dietary protein (method PronoKal ®) on a hypocaloric diet balanced in obese patients.

The main results presented show that the 6 months, patients with diet protein lose more fat and less lean mass, than patients with hypocaloric diet. In particular, of the total body weight, patients with diet protein reduced their fat mass in 9 points, while the calorie diet only in 4, which indicates a statistically significant difference. With regard to the preservation of muscle mass, the value of the group with PronoKal ® is statistically higher than the of hypocaloric diet, with 62,88% values vs. 57,34% of total body weight.

At the analytical level, both specialists also spoke of patients in study analytical improvements, that although they are present in both groups, patients who have followed the diet protein show a special improvement in the figures for total cholesterol, reaching almost in 30 units reduce the results the initial visit (205,60 mg/dL vs. 176,72 mg/dL). On the other hand, patients with hypocaloric diet have fallen only 7 units (185,15 mg/dL vs. 178,67 mg/dL). For patients with obesity and other co-morbidities, these figures are especially revealing, with dietary protein weight loss occurs mainly at the expense of fat, and this will affect a significant improvement not only in terms of decoration, but also of their State of health and quality of life.

Doctors also spoke of the figures on evolution index of Corporal mass (IMC), which at 6 months of treatment is significantly reduced in patients with PronoKal ®, until you reach a BMI of overweight (< 30), in proportion to patients with hypocaloric diet that hold grade 1 obesity (> 30), with a difference of 4,69 points between the two groups. Ultimately, these data show that the diet protein the patient begins to observe the results already in the first months of treatment, which often becomes an incentive to reinforce commitment to weight loss and maintenance in the long term.

In the words of the own Dr Casanueva, in the field of the approach of the obese patient, that usually has more difficulties for weight loss, dietary protein is positioned increasingly as an effective tool for them ”.

On the ProKal study

The ProKal study, coordinated by Dr. Basil Moreno, President of the foundation of the Spanish society for the study of obesity (SEEDO) and Chief of the service of Endocrinology and nutrition of the Hospital General Universitario Gregorio Marañón, is done in the obesity unit from the same hospital, one of the first line to Spanish level hospitals.

The study population corresponds to 80 patients of both sexes, between 18 and 65, with a BMI greater than or equal to 30, divided into 1: 1 into two groups portion. The first, the study group, is formed by obsessed patients who follow the PronoKal ® method (protein diet) for weight reduction. And the second group, control group, are obese patients who follow a hypocaloric diet balanced with a calorie intake of 10% below the basal metabolic expense, for weight reduction.

About PronoKal ®

The method PronoKal ® reaches Spain in 2004 from the hand of PronoKal ® Group, a company based in Barcelona and offices in Barcelona, Madrid and Valencia, with a team consisting of more than 200 people. This custom method is performed under medical control and is based on a scientific Protocol for more than thirty years of implementation. Today they are already more than 200,000 patients treated with the PronoKal ® method.

Its staff are dietistas-nutricionistas, giving support to the patient during the entire process of weight loss, delegates visit medical and administrative staff. In addition, as fixed collaborators has specialists in physical activity, emotional support, as well as experts in kitchen ideas creative and easy to make healthy menus that provide. The method PronoKal ®, that can only be prescribed by specially-trained doctors currently has more than 2,000 medical prescribers in Spain.